年度 | 実施人員(A) | 集 団 検 診 結 果 | 精密検査受診人員 | 精検受診率(D)/(B)+(C) | 精 密 検 査 結 果 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
乳房 精検(B) |
乳房要精検率 (B)/(A) |
甲状腺精検 (C) |
甲状腺要精検率 (C)/(A) |
経過 検査 |
その他 | 異常認めず | 乳がん (E) |
乳がん発見率 (経過含む) (E)/(A) |
甲状腺がん (F) |
甲状腺がん発見率 経過含む (F)/(A) |
乳腺症 | 線維腺腫 | 甲状腺疾病 | その他の疾病 | 異常なし | |||||||||||
S.51 | 2,158 | 78 | 3.61% | 192 | 38 | 1,850 | 77 | 98.72% | 3 | 0.139% | 45 | 4 | 18 | 7 | ||||||||||||
52 | 6,015 | 94 | 1.56% | 199 | 61 | 5,661 | 83 | 88.30% | 7 | 0.116% | 37 | 3 | 6 | 30 | ||||||||||||
53 | 6,193 | 144 | 2.33% | 39 | 71 | 5,939 | 138 | 95.83% | 8 | ※ | 3 | 0.178% | 109 | 16 | 3 | 2 | ||||||||||
54 | 7,915 | 159 | 2.01% | 62 | 98 | 7,596 | 149 | 93.71% | 8 | ※ | 4 | 0.152% | 122 | 11 | 8 | |||||||||||
55 | 7,061 | 103 | 1.46% | 117 | 1.66% | 93 | 436 | 6,312 | 89 | 40.45% | 9 | ※ | 1 | 0.142% | 57 | 18 | 3 | 2 | ||||||||
56 | 7,650 | 151 | 1.97% | 168 | 2.20% | 122 | 7,209 | 145 | 45.45% | 5 | ※ | 3 | 0.105% | 106 | 20 | 14 | ||||||||||
57 | 8,223 | 291 | 3.54% | 164 | 1.99% | 48 | 7,720 | 276 | 60.66% | 13 | 0.158% | 235 | 20 | 3 | 5 | |||||||||||
58 | 7,274 | 369 | 5.07% | 182 | 2.50% | 63 | 6,660 | 350 | 63.52% | 5 | ※ | 1 | 0.082% | 341 | 4 | |||||||||||
59 | 8,172 | 460 | 5.63% | 162 | 1.98% | 7 | 7,543 | 437 | 70.26% | 11 | 0.135% | 316 | 6 | 3 | 101 | |||||||||||
60 | 6,274 | 357 | 5.69% | 122 | 1.94% | 5,795 | 349 | 72.86% | 6 | ※ | 4 | 0.159% | 337 | 5 | 1 | |||||||||||
61 | 7,713 | 516 | 6.69% | 114 | 1.48% | 6 | 7,077 | 462 | 73.33% | 5 | 0.065% | 454 | 2 | 1 | ||||||||||||
62 | 16,526 | 1,353 | 8.19% | 373 | 2.26% | 14,800 | 1,613 | 93.45% | 15 | 0.091% | 10 | 0.061% | 1,227 | 27 | 329 | 5 | ||||||||||
63 | 28,947 | 2,493 | 8.61% | 550 | 1.90% | 25,904 | 2,700 | 88.73% | 19 | ※ | 4 | 0.079% | 12 | 0.041% | 2,120 | 21 | 453 | 75 | ||||||||
H.元 | 35,985 | 2,507 | 6.97% | 833 | 2.31% | 32,645 | 2,846 | 85.21% | 20 | ※ | 4 | 0.067% | 8 | ※ | 1 | 0.025% | 2,139 | 29 | 630 | 20 | ||||||
2 | 37,934 | 2,393 | 6.31% | 710 | 1.87% | 34,831 | 2,465 | 79.44% | 20 | ※ | 11 | 0.082% | 8 | ※ | 1 | 0.024% | 1,870 | 27 | 499 | 41 | ||||||
3 | 42,447 | 2,202 | 5.19% | 578 | 1.36% | 39,667 | 2,198 | 79.06% | 12 | ※ | 13 | 0.059% | 3 | ※ | 3 | 0.014% | 1,709 | 34 | 411 | 29 | ||||||
4 | 44,181 | 1,799 | 4.07% | 615 | 1.39% | 41,767 | 1,857 | 76.93% | 22 | ※ | 7 | 0.066% | 9 | ※ | 10 | 0.043% | 1,351 | 22 | 417 | 36 | ||||||
5 | 48,483 | 2,140 | 4.41% | 775 | 1.60% | 45,568 | 2,613 | 89.64% | 41 | ※ | 10 | 0.105% | 19 | ※ | 10 | 0.060% | 1,660 | 66 | 595 | 232 | ||||||
6 | 51,611 | 2,877 | 5.57% | 987 | 1.91% | 47,747 | 3,674 | 95.08% | 38 | ※ | 23 | 0.118% | 23 | ※ | 20 | 0.083% | 2,335 | 79 | 898 | 456 | ||||||
7 | 52,685 | 2,817 | 5.35% | 1,105 | 2.10% | 48,763 | 3,693 | 94.16% | 56 | ※ | 23 | 0.150% | 42 | ※ | 26 | 0.129% | 2,000 | 50 | 981 | 733 | ||||||
8 | 53,819 | 3,125 | 5.81% | 1,000 | 1.86% | 49,694 | 3,760 | 91.15% | 40 | ※ | 27 | 0.124% | 34 | ※ | 40 | 0.137% | 2,148 | 58 | 789 | 828 | ||||||
9 | 59,090 | 3,194 | 5.41% | 926 | 1.57% | 54,970 | 3,779 | 91.72% | 73 | ※ | 28 | 0.171% | 23 | ※ | 35 | 0.098% | 2,431 | 186 | 726 | 477 | ||||||
10 | 50,885 | 3,032 | 5.96% | 1,134 | 2.23% | 46,719 | 3,647 | 87.54% | 56 | ※ | 39 | 0.187% | 38 | ※ | 63 | 0.198% | 2,338 | 140 | 588 | 487 | ||||||
11 | 52,450 | 4,058 | 7.74% | 1,381 | 2.63% | 47,011 | 4,678 | 86.01% | 88 | ※ | 0.168% | 46 | ※ | 0.088% | 2,908 | 267 | 669 | 700 | ||||||||
12 | 52,741 | 3,984 | 7.55% | 1,287 | 2.44% | 47,470 | 5,042 | 95.66% | 67 | ※ | 0.127% | 38 | ※ | 0.072% | 2,748 | 306 | 1,097 | 786 | ||||||||
13 | 59,245 | 4,587 | 7.74% | 1,368 | 2.31% | 53,290 | 5,490 | 92.19% | 79 | 0.133% | 26 | 0.044% | 3,208 | 349 | 1.199 | 804 | ||||||||||
14 | 66,404 | 4,984 | 7.51% | 982 | 1.48% | 60,438 | 5,541 | 92.88% | 122 | 0.18% | 34 | 0.05% | 3,295 | 526 | 808 | 979 | ||||||||||
合計 | 828,081 | 50,267 | 6.07% | 15,633 | 1.89% | 831 | 704 | 760,646 | 58,151 | 88.24% | 848 | ※ | 0.102% | 373 | ※ | 0.045% | 37,646 | 2,296 | 11,107 | 6,737 | 140 |
年度 | 実施人員(A) | 集 団 検 診 結 果 | 精密検査受診人員 | 精検受診率(D)/(B)+(C) | 精 密 検 査 結 果 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
乳房精検(B) | 乳房要精検率(B)/(A) | 甲状腺精検(C) | 甲状腺要精検率(C)/(A) | 経過検査 | その他 | 異常認めず | 乳がん(E) | 乳がん発見率 (経過含む) (E)/(A) |
甲状腺がん(F) | 甲状腺がん発見率 経過含む (F)/(A) |
乳腺症 | 線維腺腫 | 甲状腺疾病 | その他の疾病 | 異常なし | |||||||||||
S.51 | 1,332 | 37 | 2.78% | 89 | 1,206 | 29 | 78.38% | 2 | 0.150% | 20 | 3 | 4 | ||||||||||||||
52 | 382 | 19 | 4.97% | 4 | 359 | 14 | 73.68% | 0.000% | 10 | 1 | 3 | |||||||||||||||
53 | 1,103 | 35 | 3.17% | 15 | 1,053 | 34 | 97.14% | 1 | 0.091% | 31 | 2 | |||||||||||||||
54 | 1,238 | 31 | 2.50% | 15 | 1,192 | 30 | 96.77% | 2 | 0.162% | 23 | 4 | 1 | ||||||||||||||
55 | 502 | 6 | 1.20% | 6 | 490 | 4 | 66.67% | 0.000% | 4 | |||||||||||||||||
56 | 523 | 12 | 2.29% | 14 | 2.68% | 10 | 487 | 11 | 42.31% | 1 | 0.191% | 9 | 1 | |||||||||||||
57 | 1,241 | 39 | 3.14% | 38 | 3.06% | 13 | 1,151 | 39 | 50.65% | 2 | 0.161% | 34 | 1 | 1 | 1 | |||||||||||
58 | 889 | 52 | 5.85% | 11 | 1.24% | 6 | 820 | 50 | 79.37% | 1 | 0.112% | 48 | 1 | |||||||||||||
59 | 834 | 54 | 6.47% | 19 | 2.28% | 6 | 755 | 50 | 68.49% | 1 | 0.120% | 40 | 1 | 8 | ||||||||||||
60 | 621 | 44 | 7.09% | 8 | 1.29% | 569 | 42 | 80.77% | 1 | 0.161% | 41 | |||||||||||||||
61 | 0 | 0 | ||||||||||||||||||||||||
62 | 48 | 3 | 6.25% | 0.00% | 45 | 4 | 133.33% | 1 | 2.083% | 3 | ||||||||||||||||
63 | 84 | 4 | 4.76% | 1 | 1.19% | 79 | 4 | 80.00% | 0.000% | 3 | 1 | |||||||||||||||
H.元 | 73 | 6 | 8.22% | 1 | 1.37% | 66 | 7 | 100.00% | 0.000% | 6 | 1 | |||||||||||||||
2 | 77 | 6 | 7.79% | 2 | 2.60% | 69 | 7 | 87.50% | 0.000% | 5 | 1 | 1 | ||||||||||||||
3 | 65 | 4 | 6.15% | 1 | 1.54% | 60 | 5 | 100.00% | 0.000% | 4 | 1 | |||||||||||||||
4 | 52 | 1 | 1.92% | 0.00% | 51 | 1 | 100.00% | 0.000% | 1 | |||||||||||||||||
5 | 6,218 | 378 | 6.08% | 122 | 1.96% | 5,718 | 354 | 70.80% | 0.000% | 1 | 0.016% | 257 | 82 | 14 | ||||||||||||
6 | 6,655 | 504 | 7.57% | 184 | 2.76% | 5,967 | 350 | 50.87% | 4 | 0.060% | 7 | 0.105% | 203 | 9 | 82 | 62 | ||||||||||
7 | 6,511 | 483 | 7.42% | 193 | 2.96% | 5,835 | 501 | 74.11% | 1 | 0.015% | 4 | 0.061% | 329 | 8 | 131 | 52 | ||||||||||
8 | 5,994 | 456 | 7.61% | 74 | 1.23% | 5,464 | 363 | 68.49% | 5 | 0.083% | 5 | 0.083% | 253 | 4 | 47 | 60 | ||||||||||
9 | 5,929 | 444 | 7.49% | 93 | 1.57% | 5,392 | 340 | 63.31% | 5 | 0.084% | 2 | 0.034% | 267 | 14 | 50 | 12 | ||||||||||
10 | 5,498 | 401 | 7.29% | 116 | 2.11% | 4,981 | 325 | 62.86% | 3 | 0.055% | 3 | 0.055% | 240 | 14 | 54 | 11 | ||||||||||
11 | 5,979 | 570 | 9.53% | 160 | 2.68% | 5,249 | 457 | 62.60% | 6 | 0.100% | 333 | 27 | 76 | 15 | ||||||||||||
12 | 5,852 | 522 | 8.92% | 170 | 2.90% | 5,160 | 374 | 54.05% | 5 | 0.085% | 262 | 21 | 68 | 18 | ||||||||||||
13 | 6,001 | 571 | 11.18% | 111 | 1.85% | 5,319 | 434 | 63.60% | 4 | 0.067% | 351 | 21 | 57 | 17 | ||||||||||||
14 | 5,886 | 390 | 6.63% | 121 | 2.06% | 5,375 | 260 | 50.88% | 10 | 0.170% | 191 | 18 | 46 | 13 | ||||||||||||
合計 | 69,587 | 5,072 | 7.29% | 1,439 | 2.07% | 164 | 62,912 | 4,089 | 62.80% | 55 | 0.079% | 22 | 0.032% | 2,968 | 151 | 701 | 279 | 9 |
年度 | 実施人員(A) | 集 団 検 診 結 果 | 精密検査受診人員 | 精検受診率(D)/(B)+(C) | 精 密 検 査 結 果 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
乳房精検(B) | 乳房要精検率(B)/(A) | 甲状腺精検(C) | 甲状腺要精検率(C)/(A) | 経過検査 | その他 | 異常認めず | 乳がん(E) | 乳がん発見率 (経過含む) (E)/(A) |
甲状腺がん(F) | 甲状腺がん発見率 経過含む (F)/(A) |
乳腺症 | 線維腺腫 | 甲状腺疾病 | その他の疾病 | 異常なし | |||||||||||
S.51 | 3,490 | 115 | 3.30% | 0 | 281 | 38 | 3,056 | 106 | 92.17% | 5 | 0 | 0.143% | 0 | 0 | 65 | 7 | 22 | 7 | 0 | |||||||
52 | 6,397 | 113 | 1.77% | 0 | 203 | 61 | 6,020 | 97 | 85.84% | 7 | 0 | 0.109% | 0 | 0 | 47 | 4 | 0 | 9 | 30 | |||||||
53 | 7,296 | 179 | 2.45% | 0 | 54 | 71 | 6,992 | 172 | 96.09% | 9 | ※ | 3 | 0.164% | 0 | 0 | 140 | 18 | 0 | 3 | 2 | ||||||
54 | 9,153 | 190 | 2.08% | 0 | 77 | 98 | 8,788 | 179 | 94.21% | 10 | ※ | 4 | 0.153% | 0 | 0 | 145 | 15 | 0 | 9 | 0 | ||||||
55 | 7,563 | 109 | 1.44% | 117 | 1.55% | 99 | 436 | 6,802 | 93 | 41.15% | 9 | ※ | 1 | 0.132% | 0 | 0 | 61 | 18 | 0 | 3 | 2 | |||||
56 | 8,173 | 163 | 1.99% | 182 | 2.23% | 132 | 0 | 7,696 | 156 | 45.22% | 6 | ※ | 3 | 0.110% | 0 | 0 | 115 | 21 | 0 | 14 | 0 | |||||
57 | 9,464 | 330 | 3.49% | 202 | 2.13% | 61 | 0 | 8,871 | 315 | 59.21% | 15 | 0 | 0.158% | 0 | 0 | 269 | 21 | 0 | 4 | 6 | ||||||
58 | 8,163 | 421 | 5.16% | 193 | 2.36% | 69 | 0 | 7,480 | 400 | 65.15% | 6 | ※ | 1 | 0.086% | 0 | 0 | 389 | 5 | 0 | 0 | 0 | |||||
59 | 9,006 | 514 | 5.71% | 181 | 2.01% | 13 | 0 | 8,298 | 487 | 70.07% | 12 | 0 | 0.133% | 0 | 0 | 356 | 7 | 0 | 3 | 109 | ||||||
60 | 6,895 | 401 | 5.82% | 130 | 1.89% | 0 | 0 | 6,364 | 391 | 73.63% | 7 | ※ | 4 | 0.160% | 0 | 0 | 378 | 5 | 0 | 1 | 0 | |||||
61 | 7,713 | 516 | 6.69% | 114 | 1.48% | 6 | 0 | 7,077 | 462 | 73.33% | 5 | 0 | 0.065% | 0 | 0 | 454 | 2 | 0 | 1 | 0 | ||||||
62 | 16,574 | 1,356 | 8.18% | 373 | 2.25% | 0 | 0 | 14,845 | 1,617 | 93.52% | 16 | 0 | 0.097% | 10 | 0 | 0.060% | 1,230 | 27 | 329 | 5 | 0 | |||||
63 | 29,031 | 2,497 | 8.60% | 551 | 1.90% | 0 | 0 | 25,983 | 2,704 | 88.71% | 19 | ※ | 4 | 0.079% | 12 | 0 | 0.041% | 2,123 | 21 | 454 | 75 | 0 | ||||
H.元 | 36,058 | 2,513 | 6.97% | 834 | 2.31% | 0 | 0 | 32,711 | 2,853 | 85.24% | 20 | ※ | 4 | 0.067% | 8 | ※ | 1 | 0.025% | 2,145 | 29 | 631 | 20 | 0 | |||
2 | 38,011 | 2,399 | 6.31% | 712 | 1.87% | 0 | 0 | 34,900 | 2,472 | 79.46% | 20 | ※ | 11 | 0.082% | 8 | ※ | 1 | 0.024% | 1,875 | 28 | 500 | 41 | 0 | |||
3 | 42,512 | 2,206 | 5.19% | 579 | 1.36% | 0 | 0 | 39,727 | 2,203 | 79.10% | 12 | ※ | 13 | 0.059% | 3 | ※ | 3 | 0.014% | 1,713 | 34 | 412 | 29 | 0 | |||
4 | 44,233 | 1,800 | 4.07% | 615 | 1.39% | 0 | 0 | 41,818 | 1,858 | 76.94% | 22 | ※ | 7 | 0.066% | 9 | ※ | 10 | 0.043% | 1,352 | 22 | 417 | 36 | 0 | |||
5 | 54,701 | 2,518 | 4.60% | 897 | 1.64% | 0 | 0 | 51,286 | 2,967 | 86.88% | 41 | ※ | 10 | 0.093% | 20 | ※ | 10 | 0.055% | 1,917 | 66 | 677 | 246 | 0 | |||
6 | 58,266 | 3,381 | 5.80% | 1,171 | 2.01% | 0 | 0 | 53,714 | 4,024 | 88.40% | 42 | ※ | 23 | 0.112% | 30 | ※ | 20 | 0.086% | 2,538 | 88 | 980 | 518 | 0 | |||
7 | 59,196 | 3,300 | 5.57% | 1,298 | 2.19% | 0 | 0 | 54,598 | 4,194 | 91.21% | 57 | ※ | 23 | 0.135% | 46 | ※ | 26 | 0.122% | 2,329 | 58 | 1,112 | 785 | 0 | |||
8 | 59,813 | 3,581 | 5.99% | 1,074 | 1.80% | 0 | 0 | 55,158 | 4,123 | 88.57% | 45 | ※ | 27 | 0.120% | 39 | ※ | 40 | 0.132% | 2,401 | 62 | 836 | 888 | 0 | |||
9 | 65,019 | 3,638 | 5.60% | 1,019 | 1.57% | 0 | 0 | 60,362 | 4,119 | 88.45% | 78 | ※ | 28 | 0.163% | 25 | ※ | 35 | 0.092% | 2,698 | 200 | 776 | 489 | 0 | |||
10 | 56,383 | 3,433 | 6.09% | 1,250 | 2.22% | 0 | 0 | 51,700 | 3,972 | 84.82% | 59 | ※ | 39 | 0.105% | 41 | ※ | 63 | 0.073% | 2,578 | 154 | 642 | 498 | 0 | |||
11 | 58,429 | 4,628 | 7.92% | 1,541 | 2.64% | 52,260 | 5,135 | 83.24% | 94 | ※ | 37 | 0.161% | 46 | ※ | 31 | 0.079% | 3,241 | 294 | 745 | 715 | ||||||
12 | 58,593 | 4,506 | 7.69% | 1,457 | 2.49% | 52,263 | 5,416 | 90.83% | 72 | ※ | 34 | 0.181% | 38 | ※ | 47 | 0.145% | 3,010 | 327 | 1,165 | 804 | ||||||
13 | 65,346 | 5,158 | 7.89% | 1,479 | 2.26% | 58,709 | 5,924 | 89.25% | 83 | ※ | 32 | 0.176% | 26 | ※ | 43 | 0.106% | 3,559 | 370 | 1,282 | 821 | ||||||
14 | 72,290 | 5,374 | 7.43% | 1,103 | 1.53% | 65,813 | 5,801 | 89.56% | 132 | ※ | 0.183% | 34 | ※ | 0.047% | 3,486 | 544 | 854 | 992 | ||||||||
合計 | 897,768 | 55,339 | 6.6% | 17,072 | 1.90% | 995 | 704 | 823,291 | 62,240 | 85.95% | 903 | ※ | 0.101% | 395 | ※ | 0.044% | 40,614 | 2,447 | 11,834 | 7,016 | 149 |